Data / Form D filings / Spyre Therapeutics, Inc.
Spyre Therapeutics, Inc.: Form D filings
Spyre Therapeutics, Inc., a biotechnology company in Waltham, MA, filed 3 Form D notices with the SEC between 2015 and 2023. The latest, on December 27, 2023, reports $180 million sold of a $180 million offering to 30 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 221 Crescent Street, Building 23, Unit 105, Waltham, MA, 02453
- Phone
- (617) 651-5940
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1636282
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 27, 2023 | New notice | $180,000,000 | $180,000,000 | 30 | Dec 11, 2023 | sec.gov | |
| Jul 6, 2023 | New notice | $210,000,248 | $210,000,248 | 41 | Jun 26, 2023 | sec.gov | |
| Mar 24, 2015 | New notice | $44,000,000 | $44,000,000 | 54 | Mar 10, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Cameron Turtle | Executive Officer, Director | |
| Tomas J. Kiselak | Director | |
| Scott Burrows | Executive Officer | |
| Laurie J. Stelzer | Director | |
| Russell J. Cox | Director | |
| Peter J. Harwin | Director | |
| Alison J. Lawton | Director | |
| Michael J. Henderson | Director | |
| Heidy King-Jones | Executive Officer | |
| Jeffrey W. Albers | Director |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Dec 25, 2023 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Spyre Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.